He pleaded guilty to one count of unlawful distribution of controlled substances in February 2020. According to the Department of Justice, Dr. Brown admitted to prescribing opioids to patients for a longer time period than was medically necessary and said he knowingly prescribed dangerous drug combinations that posed a greater risk of overdose and death.
Dr. Brown was charged in April 2019 with four others who, according to authorities, agreed to fraudulently obtain controlled substances. Prosecutors said his co-defendants obtained the controlled substances from Dayton Pharmacy, which leased space in a building he owned.
More articles on opioids:
Former Insys Therapeutics CEO to pay $5M for alleged improper opioid marketing
Physician, pharmacist lose licenses for inappropriate opioid dispensing, Medicare fraud
McKinsey reaches $573M settlement with 47 states for role in opioid epidemic
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
